BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

319 related articles for article (PubMed ID: 9727088)

  • 1. 5-Hydroxytryptophan: a clinically-effective serotonin precursor.
    Birdsall TC
    Altern Med Rev; 1998 Aug; 3(4):271-80. PubMed ID: 9727088
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fibromyalgia and the serotonin pathway.
    Juhl JH
    Altern Med Rev; 1998 Oct; 3(5):367-75. PubMed ID: 9802912
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serotonin a la carte: supplementation with the serotonin precursor 5-hydroxytryptophan.
    Turner EH; Loftis JM; Blackwell AD
    Pharmacol Ther; 2006 Mar; 109(3):325-38. PubMed ID: 16023217
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 5-hydroxytryptophan.
    Altern Med Rev; 1998 Jun; 3(3):224-6. PubMed ID: 9630740
    [No Abstract]   [Full Text] [Related]  

  • 5. Effect of narcotics on the uptake of serotonin precursors by the rat brain.
    Larson AA; Takemori AE
    J Pharmacol Exp Ther; 1977 Jan; 200(1):216-23. PubMed ID: 299890
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Management of depression with serotonin precursors.
    van Praag HM
    Biol Psychiatry; 1981 Mar; 16(3):291-310. PubMed ID: 6164407
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Hypothetical concept: the physiopathological entity of monoaminergic psychoses].
    Tissot R
    Encephale; 1975; 1(4):289-339. PubMed ID: 1082812
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of oral 5-HTP administration on 5-HTP and 5-HT immunoreactivity in monoaminergic brain regions of rats.
    Lynn-Bullock CP; Welshhans K; Pallas SL; Katz PS
    J Chem Neuroanat; 2004 May; 27(2):129-38. PubMed ID: 15121217
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Serotonin precursors as antidepressive agents: a review].
    Beckmann H; Kasper S
    Fortschr Neurol Psychiatr; 1983 May; 51(5):176-82. PubMed ID: 6603403
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 5-Hydroxytryptophan: a review of its antidepressant efficacy and adverse effects.
    Byerley WF; Judd LL; Reimherr FW; Grosser BI
    J Clin Psychopharmacol; 1987 Jun; 7(3):127-37. PubMed ID: 3298325
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serotonin precursors in the treatment of depression.
    van Praag HM
    Adv Biochem Psychopharmacol; 1982; 34():259-86. PubMed ID: 6753514
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 5-HTP hypothesis of schizophrenia.
    Fukuda K
    Med Hypotheses; 2014 Jan; 82(1):20-3. PubMed ID: 24280562
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The central or peripheral nature of pain in essential headaches].
    Sicuteri F; Fonda C
    Minerva Med; 1976 Jun; 67(28):1826-33. PubMed ID: 180458
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Localization and quantification of 5-hydroxytryptophan and serotonin in the central nervous systems of Tritonia and Aplysia.
    Fickbohm DJ; Lynn-Bullock CP; Spitzer N; Caldwell HK; Katz PS
    J Comp Neurol; 2001 Aug; 437(1):91-105. PubMed ID: 11477599
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Measurement of 5-hydroxyindole compounds during L-5-HTP treatment in depressed patients.
    Takahashi S; Takahashi R; Masumura I; Miike A
    Folia Psychiatr Neurol Jpn; 1976; 30(4):461-73. PubMed ID: 1087913
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metabolic engineering of Escherichia coli for efficient production of L-5-hydroxytryptophan from glucose.
    Zhang Z; Yu Z; Wang J; Yu Y; Li L; Sun P; Fan X; Xu Q
    Microb Cell Fact; 2022 Sep; 21(1):198. PubMed ID: 36153615
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Depression and serotonin metabolism: rationale for neurotransmitter precursor treatment.
    Byerley WF; Risch SC
    J Clin Psychopharmacol; 1985 Aug; 5(4):191-206. PubMed ID: 2410463
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Safety of 5-hydroxy-L-tryptophan.
    Das YT; Bagchi M; Bagchi D; Preuss HG
    Toxicol Lett; 2004 Apr; 150(1):111-22. PubMed ID: 15068828
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 5-Hydroxytryptamine and pain modulation in man: a clinical pharmacological approach with tryptophan and parachlorophenylalanine.
    Sicuteri F; Anselmi B; Del Bene E; Galli P
    Acta Vitaminol Enzymol; 1975; 29(1-6):66-8. PubMed ID: 146417
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serotonergic disturbances in autistic disorder: L-5-hydroxytryptophan administration to autistic youngsters increases the blood concentrations of serotonin in patients but not in controls.
    Croonenberghs J; Verkerk R; Scharpe S; Deboutte D; Maes M
    Life Sci; 2005 Mar; 76(19):2171-83. PubMed ID: 15733932
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.